✦ LIBER ✦

Increase of bone alkaline phosphatase after androgen deprivation therapy in patients with prostate cancer

✍ Scribed by Juan Morote; Youssef I.D M’Hammed; Esther Martinez; Salvador Esquena; Jose Antonio Lorente; Antonio Gelabert

Book ID: 117264127
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 88 KB
Volume: 59
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(01)01518-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone Loss after Initiation of Androgen D

Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer

✍ Greenspan, Susan L.; Coates, Penelope; Sereika, Susan M.; Nelson, Joel B.; Trump 📂 Article 📅 2005 🏛 Endocrine Society 🌐 English ⚖ 251 KB

Androgen Deprivation Therapy in Patients

Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer

✍ Robert Dreicer 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 112 KB

Risedronate Recovers Bone Loss in Patien

Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation Therapy

✍ Kouji Izumi; Atsushi Mizokami; Kazuhiro Sugimoto; Kazutaka Narimoto; Sotaro Miwa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Reversibility of androgen deprivation th

Reversibility of androgen deprivation therapy in patients with prostate cancer

✍ A. Fridmans; B. Chertin; I. Spitz; A. Farkas 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 203 KB

REVERSIBILITY OF ANDROGEN DEPRIVATION TH

REVERSIBILITY OF ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER

✍ FRIDMANS, A; CHERTIN, B; KOULIKOV, D; LINDENBERG, T; GELBER, H; LEITER, C; FARKA 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 336 KB

Androgen deprivation therapy increases c

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec